trending Market Intelligence /marketintelligence/en/news-insights/trending/dlb_u1thxnyduu0sn0vp2g2 content esgSubNav
In This List

Wright Medical Group completes $435M acquisition of medical device maker Cartiva

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Wright Medical Group completes $435M acquisition of medical device maker Cartiva

Wright Medical Group NV completed the $435 million acquisition of privately held medical device company Cartiva Inc.

The deal was an all-cash transaction funded by a public offering of common shares conducted by the Amsterdam-based company in August.

Alpharetta, Ga.-based Cartiva develops and sells devices focused on the treatment of degenerative joint disease or osteoarthritis.

With the acquisition, Wright Medical adds Cartiva's lead product, a synthetic cartilage implant for treating arthritis of the big toe, to its existing portfolio.

"With approximately 120,000 procedures for great toe arthritis performed each year in the U.S., we believe that this technology provides a proven alternative to fusion that reduces joint pain without sacrificing the foot’s natural movement and retains mobility and range of motion," Wright Medical President and CEO Robert Palmisano said in a statement.